Recommendations
This section contains a list of the policy recommendations of the Pan Mersey Area Prescribing Committee.
Reviews of the new medicines have been conducted by our pharmacists using a number of resources including National Institute for Health and Clinical Excellence (NICE) which is a Special health Authority (SHA) set up in 1999. It is used to give advice to the NHS on best clinical practice including the clinical and cost effectiveness of drugs and other treatments.
Definitions and criteria for the categorisation of medicines
Legacy Merseyside
New Cheshire and Merseyside
Transition of Commissioning Policies
On 1st July 2022 NHS Cheshire and Merseyside Integrated Care Board (ICB) became the new statutory body responsible for ensuring health care services are available to meet the reasonable needs of the people of Cheshire & Merseyside.
Until such time as a single suite of commissioning policies can be developed and adopted, NHS Cheshire and Merseyside will continue to adopt and operate the CCG policies it has inherited at Place/borough level, which means that there will be no immediate change in commissioning policy for local people resident in those Places/boroughs from what was in place prior to 1st July 2022.
Documents
The Pan Mersey Area Prescribing Committee recommends the prescribing of CICLOSPORIN 1mg/mL eye drops (Verkazia®), by specialists only, for the treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents.
The Pan Mersey Area Prescribing Committee recommends the prescribing of DEXAMETHASONE INTRAVITREAL IMPLANT (Ozurdex®), by specialists only, for treating visual impairment caused by diabetic macular oedema, in accordance with NICE TA824.
NHS Cheshire and Merseyside APPROVED
The Pan Mersey Area Prescribing Committee recommends the prescribing of FARICIMAB solution for injection (Vabysmo®▼), by specialists only, for diabetic macular oedema in accordance with NICE TA799.
NHS Cheshire and Merseyside APPROVED
The Pan Mersey Area Prescribing Committee recommends the prescribing of FARICIMAB solution for injection (Vabysmo ®▼), by specialists only, for neovascular (wet) age-related macular degeneration in accordance with NICE TA800.
NHS Cheshire and Merseyside APPROVED
The Pan Mersey Area Prescribing Committee recommends the prescribing of RANIBIZUMAB intravitreal injection (Lucentis®), by ophthalmologists only, for the treatment of visual impairment secondary to choroidal neovascularisation (CNV) in conditions not covered by NICE technology appraisals.